PL88702B1 - - Google Patents

Download PDF

Info

Publication number
PL88702B1
PL88702B1 PL1974169035A PL16903574A PL88702B1 PL 88702 B1 PL88702 B1 PL 88702B1 PL 1974169035 A PL1974169035 A PL 1974169035A PL 16903574 A PL16903574 A PL 16903574A PL 88702 B1 PL88702 B1 PL 88702B1
Authority
PL
Poland
Prior art keywords
carboxylic acid
ester
chlorocephem
solution
mmol
Prior art date
Application number
PL1974169035A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL88702B1 publication Critical patent/PL88702B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL1974169035A 1973-02-23 1974-02-23 PL88702B1 (en, 2012)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33538173A 1973-02-23 1973-02-23

Publications (1)

Publication Number Publication Date
PL88702B1 true PL88702B1 (en, 2012) 1976-09-30

Family

ID=23311540

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1974169035A PL88702B1 (en, 2012) 1973-02-23 1974-02-23

Country Status (37)

Country Link
JP (4) JPS6139313B2 (en, 2012)
AR (1) AR199510A1 (en, 2012)
AT (1) AT333953B (en, 2012)
BE (1) BE811495A (en, 2012)
BR (1) BR7401384D0 (en, 2012)
CA (1) CA1016537A (en, 2012)
CH (1) CH593988A5 (en, 2012)
CS (1) CS187409B2 (en, 2012)
CY (1) CY1043A (en, 2012)
DD (1) DD110278A5 (en, 2012)
DE (1) DE2408698C2 (en, 2012)
DK (1) DK153157C (en, 2012)
EG (1) EG11104A (en, 2012)
ES (1) ES423531A1 (en, 2012)
FI (2) FI63035C (en, 2012)
FR (1) FR2218877B1 (en, 2012)
GB (1) GB1461323A (en, 2012)
GT (1) GT197432133A (en, 2012)
HK (1) HK20080A (en, 2012)
HU (1) HU166849B (en, 2012)
IE (1) IE39046B1 (en, 2012)
IL (1) IL44262A (en, 2012)
IN (1) IN139620B (en, 2012)
KE (1) KE3027A (en, 2012)
MW (1) MW674A1 (en, 2012)
MY (1) MY8100024A (en, 2012)
NL (1) NL179057C (en, 2012)
NO (2) NO148375C (en, 2012)
OA (1) OA04809A (en, 2012)
PH (1) PH9616A (en, 2012)
PL (1) PL88702B1 (en, 2012)
RO (1) RO64663A (en, 2012)
SE (1) SE411212B (en, 2012)
SU (1) SU676166A3 (en, 2012)
YU (1) YU36970B (en, 2012)
ZA (1) ZA741191B (en, 2012)
ZM (1) ZM3574A1 (en, 2012)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342197B (de) * 1975-02-20 1978-03-28 Ciba Geigy Ag Neues verfahren zur herstellung von 3-cephemverbindungen
CH619233A5 (en, 2012) * 1975-07-31 1980-09-15 Ciba Geigy Ag
CH622802A5 (en, 2012) * 1975-08-20 1981-04-30 Ciba Geigy Ag
IE45158B1 (en) * 1976-08-16 1982-06-30 Lilly Co Eli 3-chloro-cephem synthesis
DE3508258A1 (de) * 1985-03-08 1986-09-18 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
DE3509618A1 (de) * 1985-03-16 1986-09-18 Bayer Ag, 5090 Leverkusen Ss-lactam-antibiotika, verfahren zur herstellung und ihre verwendung als arzneimittel
JPS6436445U (en, 2012) * 1987-08-28 1989-03-06
DE3803169A1 (de) 1988-02-03 1989-08-17 Bayer Ag Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln
ES2010075A6 (es) * 1989-01-10 1989-10-16 Antibioticos Sa Un procedimiento para la preparacion de compuestos de 3-cloro-cefem.
JP2539459Y2 (ja) * 1991-12-18 1997-06-25 三重ホーロー株式会社 組立式塵芥焼却器
IT1255458B (it) * 1992-05-11 1995-11-02 Col Marco Da Procedimento per la preparazione di derivati beta-lattamici alogenati
ES2079327B1 (es) 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
CN101805357B (zh) * 2010-04-28 2012-01-11 陶灵刚 一种头孢克洛化合物及其制法
CN103588790A (zh) * 2013-11-29 2014-02-19 中国科学院长春应用化学研究所 7-氨基-3-氯-3-头孢-4-羧酸-对硝基苄基酯的制备方法
CN106632400A (zh) * 2016-12-16 2017-05-10 石家庄柏奇化工有限公司 Pd‑C催化氢化脱除4‑硝基苄基制备7‑ACCA的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
FR2143211B1 (en, 2012) * 1971-06-24 1975-10-31 Fujisawa Pharmaceutical Co
AR206201A1 (es) * 1972-06-29 1976-07-07 Ciba Geigy Ag Procedimiento para la obtencion de compuestos de acido 7beta-amino-3-cefem-3-01-4-carboxilico0-substituidos

Also Published As

Publication number Publication date
DK153157C (da) 1988-10-31
CY1043A (en) 1980-08-01
JPS49110689A (en, 2012) 1974-10-22
JPS56138192A (en) 1981-10-28
NO148377C (no) 1983-09-28
NO148375B (no) 1983-06-20
JPS6140235B2 (en, 2012) 1986-09-08
NL179057C (nl) 1986-07-01
ZA741191B (en) 1975-10-29
FR2218877A1 (en, 2012) 1974-09-20
MW674A1 (en) 1975-04-09
KE3027A (en) 1980-03-14
SU676166A3 (ru) 1979-07-25
JPS6140236B2 (en, 2012) 1986-09-08
NL7402489A (en, 2012) 1974-08-27
JPS6139313B2 (en, 2012) 1986-09-03
BR7401384D0 (pt) 1974-11-05
IN139620B (en, 2012) 1976-07-10
CH593988A5 (en, 2012) 1977-12-30
NO792681L (no) 1974-08-26
SE411212B (sv) 1979-12-10
FI63035C (fi) 1983-04-11
JPS56138191A (en) 1981-10-28
FR2218877B1 (en, 2012) 1977-03-11
BE811495A (fr) 1974-08-22
CA1016537A (en) 1977-08-30
MY8100024A (en) 1981-12-31
GT197432133A (es) 1975-08-16
IE39046L (en) 1974-08-23
OA04809A (fr) 1980-08-31
FI793178A7 (fi) 1981-01-01
ES423531A1 (es) 1976-05-16
AT333953B (de) 1976-12-27
DE2408698A1 (de) 1974-09-05
NL179057B (nl) 1986-02-03
CS187409B2 (en) 1979-01-31
AR199510A1 (es) 1974-09-09
JPS56138190A (en) 1981-10-28
ATA142574A (de) 1976-04-15
GB1461323A (en) 1977-01-13
YU36970B (en) 1984-08-31
IL44262A0 (en) 1974-05-16
NO148377B (no) 1983-06-20
HU166849B (en, 2012) 1975-06-28
PH9616A (en) 1976-01-20
NO740606L (no) 1974-08-26
RO64663A (fr) 1979-02-15
EG11104A (en) 1976-12-31
DD110278A5 (en, 2012) 1974-12-12
HK20080A (en) 1980-04-25
DE2408698C2 (de) 1983-11-10
YU39974A (en) 1982-06-18
IE39046B1 (en) 1978-07-19
AU6591674A (en) 1975-08-28
IL44262A (en) 1977-08-31
NO148375C (no) 1983-09-28
JPS6140237B2 (en, 2012) 1986-09-08
FI63035B (fi) 1982-12-31
DK153157B (da) 1988-06-20
ZM3574A1 (en) 1975-11-21

Similar Documents

Publication Publication Date Title
US3925372A (en) Alpha-aminoacyl-3-halo cephalosporins
US3992377A (en) 3-Thio-substituted cephalosporin antibiotics
PL88702B1 (en, 2012)
US3962227A (en) 3-halo cephalosporins
DE2331133C2 (de) O-Substituierte 7β-Amino-2- oder 3-cephem-3-ol-4-carbonsäureverbindungen
US4064343A (en) 3-Halo cephalosporins
US3351596A (en) 3-formyl cephalosporins
US3917588A (en) {60 -Aminoacyl cephalosporin ethers
US3849408A (en) 4-substituted-delta2-cephalosporin derivatives
US4492692A (en) Cephalosporin derivatives
CH622523A5 (en, 2012)
US4001226A (en) 3-(substituted)carbonylamino cephem derivatives
FI63240B (fi) Analogifoerfarande foer framstaellning av antibakteriella 3-klorcefalosporinderivat
DE2239947A1 (de) Cephalosporinverbindungen und verfahren zu deren herstellung
US4208515A (en) 3-Halo cephalosporins
US3985737A (en) 3-Sulfonate esters of cephalosporin
DE2262500A1 (de) 3-oxyiminomethylcephalosporinverbindungen
JPH0521912B2 (en, 2012)
US4252950A (en) 3-Halo cephalosporins
US4281116A (en) 3-Halo cephalosporins
GB2137998A (en) Benzothienyl cephalosporin antibiotics
GB2045233A (en) Unsaturated 3-heterocyclyl- thiomethyl-7???-methoxy-7???- acylamido-3-cephem-4- carboxylic acid derivatives
US4260745A (en) 3-Halo cephalosporins
DE2517047A1 (de) 3,4-dicarboxycephalosporine und derivate hiervon
JPS5965095A (ja) 抗菌性化合物およびその製造方法